{"id":"NCT00935818","sponsor":"Mayo Clinic","briefTitle":"Varenicline and Bupropion for Smoking Cessation","officialTitle":"Combination Therapy With Varenicline and Bupropion for Smoking Cessation","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2009-09","primaryCompletion":"2013-04","completion":"2013-04","firstPosted":"2009-07-09","resultsPosted":"2014-04-24","lastUpdate":"2014-05-09"},"enrollment":506,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Smoking"],"interventions":[{"type":"DRUG","name":"Varenicline","otherNames":["chantix"]},{"type":"DRUG","name":"placebo","otherNames":["sugar pill"]},{"type":"DRUG","name":"bupropion SR","otherNames":["wellbutrin SR","zyban"]}],"arms":[{"label":"varenicline and buproprion SR","type":"ACTIVE_COMPARATOR"},{"label":"varenicline and placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study provides an opportunity to combine varenicline and bupropion SR and capitalize on the potential additive benefit. The investigators hypothesize that this will further increase long-term (â‰¥ 6 months) smoking abstinence rates.","primaryOutcome":{"measure":"Prolonged Smoking Abstinence Rates at 12 Weeks in Cigarettes Smokers.","timeFrame":"3 months","effectByArm":[{"arm":"Varenicline and Buproprion SR","deltaMin":132,"sd":null},{"arm":"Varenicline and Placebo","deltaMin":111,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.03"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":3,"countries":["United States"]},"refs":{"pmids":["24399554","37142273","34611902"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":249},"commonTop":["sleep disturbance","nausea","constipation","headache","irritability"]}}